You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Latest drug used for treatment of MDR TB patients is - and explain in detail?
Ans. is 'a' i.e., Bedaquiline Bedaquiline* It is a diaryl quinolone.* It acts by inhibiting M. tuberculosis adenosine triphosphate synthase.* It demonstrates significant potency against M. tuberculosis infection, both drug susceptible and multidrug resistant strains as well as many other mycobacteria.* It has potential to shorten the duration of drug therapy for management M. tuberculosis infection.* It is associated with nausea, increased QT interval.* FT, has approved bedaquiline for the management of drug resistant tuberculosis with a black box warning, relating to possible cardiac toxicity and sudden death.Note:DELAMANID:* It is also a new agent derived from nitrodihydro-imidazooxazole class of compounds.* It inhibits mycolic acid synthesis, and has shown potent in vitro and invivo activity against both drug susceptible and drug resistant M. tuberculosis strains.